Estrogen and mood in women

Endocrinologist

Volumn 15, Issue 3, 2005, Pages 180-185

  Sherwin, Barbara B ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c PFIZER INC   (United States)

Author keywords

Estrogen; Menopause; Mood; Postpartum depression; Premenstrual dyphoric disorder

Indexed keywords

CITALOPRAM; CONJUGATED ESTROGEN; DYDROGESTERONE; ESTROGEN; FLUOXETINE; GONADORELIN DERIVATIVE; NEUROTRANSMITTER; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

CLIMACTERIUM; DEPRESSION; DRUG EFFICACY; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HUMAN; INVOLUTIONAL DEPRESSION; MENSTRUAL CYCLE; MOOD DISORDER; PREMENSTRUAL DYSPHORIC DISORDER; PUERPERAL DEPRESSION; PUERPERIUM; REPRODUCTION; REVIEW; SEROTONINERGIC SYSTEM;

EID: 18844411106     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000162373.22576.7d     Document Type: Review

References (51)

1. Kessler R. Gender and mood disorders. In: Goldman MB, Hatch MC, eds. Women and Health. San Diego: Academic Press; 2000:989-996.
2. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276:293-299.
3. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
4. Merinkangas KR, Weissman MM, Pauls DL, et al. Genetic factors in the sex ratio of major depression. Psychol Med. 1985;15:63-69.
5. Dohrenwend BP, Dohrenwend BS. Sex differences in psychiatric disorders. Am J Social. 1977;82:1136-1145.
6. Kessler RC, Reuter JA, Greenlay JR. Sex difference in the use of psychiatric outpatient facilities. Social Forces. 1979;58:557-571.
7. Radloff LS, Rai DS. Susceptibility and precipitating factors in depression: sex differences and similarities. J Abnorm Psychol. 1979;88:174-181.
8. MacIntyre S, Oldman D. Coping with migraine. In: Horobin G, Davis A, eds. Medical Encounters. London: Croom Helm; 1977:61-72.
9. Angold A, Costello EJ, Worthman CM. Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med. 1998;28:51-61.
10. Lunine VN, Khylehevskaya RI, McEwen B. Effects of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res. 1975;86:293-306.
11. Halbreich U, Rojansky N, Palter S, et al. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry. 1995;37:434-441.
12. McEwen BS, Alves SE, Bullock K. Ovarian steroids and the brain: implications for cognition and aging. 1997;48(suppl 7):S8-15.
13. Kugaya A, Epperson CN, Zoghbi S, et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry. 2003;160:1522-1524.
14. Diagnostic and Statistical Manual of Mental Disorders, Fourth ed. Washington, DC: American Psychiatric Association; 1994.
15. Angst J, Sellaro R, Merikangas KR, et al. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand. 2001;104:110-116.
16. Halbreich U, Rojansky N, Palter S. Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. Fertil Steril. 1991;56:1066-1069.
17. Schmidt PJ, Nieman LK, Danaceau MA, et al. Differential behavioral effects of gonadal steroids in women with and those without premenstrual syndrome. N Engl J Med. 1998;338:209-216.
18. Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med. 1995;332:1529-1534.
19. Yonkers KA, Halbreich U, Freeman E, et al. Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull. 1996;32:41-46.
20. Yonkers KA, Halbreich U, Freeman, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. JAMA. 1997;278:983-988.
21. Steiner M, Born L. Advances in the diagnosis and treatment of premenstrual dysphoria. CNS Drugs. 2000;13:286-304.
22. Stein G, Marsh A, Morton J. Mental symptoms, weight changes and electrolyte excretion in the first postpartum week. J Psychosom Res. 1981;25:395-408.
23. O'Hara MW, Schlechte JA, Lewis DA, et al. Prospective study of postpartum blues: biologic and psychosocial factors. Arch Gen Psychiatry. 1991;48:801-806.
24. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry. 1993;163:27-31.
25. O'Hara MW, Zekoski EM, Phillipps LH, et al. Controlled prospective study of postpartum mood disorders: comparison of childbearing and non-childbearing women. J Abnorm Psychol. 1990;99:3-15.
26. Carothers AD, Murray L. Estimating psychiatric morbidity by logistic regression: application to post-natal depression in a community sample. Psychol Med. 1990;20:695-702.
27. Cooper PJ, Murray L, Hooper R, et al. The development and validation of a predictive index for postpartum depression. Psychol Med. 1996;26:627-634.
28. Kumar R, Robson KM. A prospective study of emotional disorders in childbearing women. Br J Psychiatry. 1984;144:35-47.
29. Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord. 2003;74:67-83.
30. Gregoire AJ, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347:930-933.
31. Gitlin MJ, Pasau RO. Psychiatric syndromes linked to reproductive function in women. Am J Psychiatry. 1989;145:1413-1422.
32. Ahokas A, Kaukoranta J, Aito M. Effect of oestradiol on postpartum depression. Psychopharmacology. 1999;146:108-110.
33. Schmidt PJ, Rubinow DR. Menopause-related affective disorders: a justification for further study. Am J Psychiatry. 1991;148:844-852.
34. Anderson E, Hamburger S, Liu JH, et al. Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol. 1987;156:428-433.
35. Avis NE, Brambilla D, Mc Kinlay SE, et al. A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women's Health Study. Ann Epidemiol. 1994;4:214-220.
36. Avis NE, McKinlay SE. A longitudinal analysis of women's attitudes toward the menopause: results from the Massachusetts Women's Health Study. Maturitas. 1991;13:65-79.
37. Hunter MS. Depression and the menopause. BMJ. 1996;313:1218-1218.
38. Schmidt PJ, Roca CA, Bloch M, et al. The perimenopause and affective disorders. Semin Reprod Endocrinol. 1997;15:91-100.
39. Bromberger JT, Meyer PM, Kravitz HM, et al. Psychologic distress and natural menopause: a multiethnic community sample. Am J Public Health. 2001;91:1435-1442.
40. Freeman EW, Sammel MD, Liu L, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004;61:62-70.
41. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord. 1988;14:177-187.
42. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: a double-blind, cross-over study. Psychoneuroendocrinology. 1985;10:325-335.
43. Sherwin BB, Suranyi-Cadotte BE. Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women. Biol Psychiatry. 1990;28:339-348.
44. Ditkoff EC, Crary WG, Cristo M, et al. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol. 1991;78:991-995.
45. Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol. 2000;183:414-420.
46. Soares CN, Almeida OP, Joffe H, et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch Gen Psychiatry. 2001;58:529-534.
47. Morrison MF, Kallan MJ, Ten Have T, et al. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry. 2004;55:406-412.
48. Cohen LS, Soares CN, Poitras JR, et al. Short-term use of estradiol for depression in perimenopausal and postmenopausal women. Am J Psychiatry. 2003;160:1519-1522.
49. Amsterdam J, Garcia-Espana F, Fawcett J, et al. Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord. 1999;55:11-17.
50. Rasgon NL, Altshuler LL, Fairbanks LA, et al. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry. 2002;63(suppl 7):45-48.
51. Soares CN, Poitras JR, Prouty J, et al. Efficacy of citalopram as monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. J Clin Psychiatry. 2003;64:473-479.